As of Apr 20
| -0.05 / -2.14%|
The 5 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.00, with a high estimate of 9.50 and a low estimate of 3.30. The median estimate represents a +118.34% increase from the last price of 2.29.
The current consensus among 5 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.